Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Clinical trial NCT05849220 · UNKNOWN
Trial details
- NCT number
- NCT05849220
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2024-03-30
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.